Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
170.69
+2.81 (1.67%)
At close: Aug 21, 2026, 4:00 PM EDT
170.65
-0.04 (-0.02%)
After-hours: Aug 21, 2026, 7:30 PM EDT

Guardant Health Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-453.44-416.28-436.37-479.45-654.59-405.67
Depreciation & Amortization
38.4639.7442.3942.8835.9622.27
Other Amortization
----2.572.56
Loss (Gain) From Sale of Investments
0.5212.7137.63-64.2117.6512.85
Stock-Based Compensation
191.33166.22140.4190.7694.69151.45
Other Operating Activities
46.3227.2936.9531.2132.747.99
Change in Accounts Receivable
-13.69-28.18-21.398.380.38-44.35
Change in Inventory
-21.4-14.79-9.14-10.35-20.93-7.96
Change in Accounts Payable
93.0852.75-2.825.1960.3334.8
Change in Unearned Revenue
-7.6219.4618.661.739.872.78
Change in Other Net Operating Assets
-58.75-43.67-46.1848.8911.91-25.73
Operating Cash Flow
-185.19-184.76-239.86-324.98-309.46-209.02
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-55.54-48.31-35.09-20.49-77.46-75.04
Cash Acquisitions
-58.99-58.99----
Investment in Securities
-4-519.91-226.22860.74227.2811.88
Investing Cash Flow
-118.53-627.2-261.31840.25149.82-63.16

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-402.5----
Net Debt Issued (Repaid)
402.5402.5----
Issuance of Common Stock
399.74377.8114.84503.6811.9417.87
Repurchase of Common Stock
-36.59-75.55-15.68-11.2-7.88-83.76
Other Financing Activities
-27.86-33.63-0.15-15.1-193.16-0.93
Financing Cash Flow
737.8671.13-1477.38-189.09-66.82

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-1.820.49-1.77-0.91-1.6-1.69
Net Cash Flow
432.26-140.34-503.93991.74-350.34-340.69

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-240.72-233.07-274.94-345.46-386.92-284.05
Free Cash Flow Growth
------
Free Cash Flow Margin
-20.35%-23.73%-37.20%-61.26%-86.07%-76.02%
Free Cash Flow Per Share
-1.86-1.86-2.24-3.08-3.79-2.80
Levered Free Cash Flow
26.61-88.11-148.78-180.7-295.57-123.48
Unlevered Free Cash Flow
29.62-85.67-147.16-179.09-296.52-124.43

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
3.773.77----
Cash Income Tax Paid
0.870.871.011.971.330.39
Change in Working Capital
-8.38-14.43-60.8653.8461.56-40.47
SEC Filings: 10-K · 10-Q